Rybodyn

Developer of immunotherapies for the treatment of cancer

placeSan Diego, California, United States calendar_todayFounded 2022 groups3 employees language rybodyn.com

Social engagement

Social engagement: 1.3K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include EvoNexus, Genedant, SeaX Ventures.

Investor typeCountShare
Venture capital480%
Accelerator & incubator120%

Recent activity

1 Jul 2026
Event
SEA Health Summit 2026
20 Jun 2026
Leadership hire
Computational Biologist II
19 Mar 2026
Leadership hire
Vice President, Corporate Strategy
Coming soon